Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/CNS Pharmaceuticals, Inc./ 424B3

SEC Filing · 424B3

CNS Pharmaceuticals, Inc.

CNSPNASDAQEQUITYCurrent

SEC Filing

Filed May 26, 2026Accepted May 26, 2026, 5:01 PM EDTCIK 1729427Accession 0001683168-26-004304
View company →Permanent SEC source ↗
Share

Company context

Current securities

CNSPNASDAQ · EQUITY · Current

Recent company filings

  1. DEFA14A filingAug 25, 2026
  2. DEF 14A filingAug 21, 2026
  3. SCHEDULE 13G/A filingAug 14, 2026
  4. 10-Q filingAug 12, 2026
  5. Regulation FD DisclosureJul 2, 2026

As-filed source

Primary evidence
As filedOpen full document ↗